DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

NexLife alternatives: what else costs less or bills differently

As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan, and $109 or $95 for semaglutide, the same price at every dose with no membership. Price check, month to month and all-in: tirzepatide: Collective $85.58 a month all-in, including its $199 annual membership, Mondae $126 a month; Eden charges the same; semaglutide: Collective $75.58 a month all-in, including its $199 annual membership, Mondae $87 a month, Yucca Health $89 a month, Eden $99 a month.

Released · Last reviewed · how we verify

Tirzepatide: programs around NexLife

Like-for-like basis: compounded tirzepatide, month to month, all-in, read on each program’s own page on November 20, 2026. NexLife: $129 a month.

Compounded tirzepatide programs below, at and above NexLife’s month-to-month price, sorted by a year’s cost (read November 20, 2026)
ProgramMonth to month, all-inBasisYear at that priceLowest printed rateRead
Collective$85.58per month$1,027$85.58 ($69 a month plus $199 a year)2026-11-20
Mondae$126per month$1,512$114 (6-month plan, $684)2026-11-20
Eden$129per month$1,548$129 (every month)2026-11-20
Yucca Health$139per month$1,668$119 (12-month plan, $1,428 upfront)2026-11-20
Fifty 410$199per 28-day cycle$2,587$149.50 (8-week program at $299, not in all states)2026-11-20
Emerge Weight Loss$269per 28-day cycle$3,497$224 (2.5 mg, per 4 weeks)2026-11-20

Semaglutide: programs around NexLife

Like-for-like basis: compounded semaglutide, month to month, all-in, read on each program’s own page on November 20, 2026. NexLife: $109 a month.

Compounded semaglutide programs below, at and above NexLife’s month-to-month price, sorted by a year’s cost (read November 20, 2026)
ProgramMonth to month, all-inBasisYear at that priceLowest printed rateRead
Collective$75.58per month$907$75.58 ($59 a month plus $199 a year)2026-11-20
Mondae$87per month$1,044$69 (6-month plan, $414)2026-11-20
Yucca Health$89per month$1,068$69 (12-month plan, $828 upfront)2026-11-20
Eden$99per month$1,188$99 (every month)2026-11-20
OrderlyMeds$149per month$1,788$74 (2-month new-customer offer, $149)2026-11-20
Fifty 410$199per 28-day cycle$2,587$199 (4-week program)2026-11-20
Noom Med$249per 28-day cycle$3,237$249 (per 4 weeks, billed every 12 weeks)2026-11-20

Brand alternatives

FDA-approved brand medication bought direct costs more: Zepbound vials from $299 at 2.5 mg to $449 a month at 7.5–15 mg with refills inside 45 days (LillyDirect, ladder carried from October 15), and Wegovy pens $349 a month (NovoCare, read November 20, 2026). Insurance coverage of a brand drug usually beats any cash price; see the insurance page.

Limitations

Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. Switching programs means a new prescriber review; ask the new program how it handles your current dose.

Frequently asked

What is the main alternative to NexLife?

As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan, and $109 or $95 for semaglutide, the same price at every dose with no membership. Price check, month to month and all-in: tirzepatide: Collective $85.58 a month all-in, including its $199 annual membership, Mondae $126 a month; Eden charges the same; semaglutide: Collective $75.58 a month all-in, including its $199 annual membership, Mondae $87 a month, Yucca Health $89 a month, Eden $99 a month.

How are alternatives chosen here?

By the same basis for every program: the compounded month-to-month, all-in price at the maintenance dose, read on the program’s own page on November 20, 2026, turned into a year’s cost (12 months, or 13 four-week cycles). Programs that print only a starting-dose or coupon price are listed separately, because their regular cost cannot be confirmed.

NexLife recordAll alternativesRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.